FDAFDA · Food and drugs·Recall number Z-2308-2012
Status Flu A + B Test Manufactured by Princeton Bio Meditech Corporation Monmouth Junction, NJ 08852 USA. The BioSign Flu A + B test is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab, nasopharyngeal swab and nasal pharyngeal aspirate/wash specimens obtained from patients with signs and symptoms of respiratory infection. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections. A negative test result is presumptive and it recommended that these results be confirmed by viral culture. Negative results do not preclude influenza virus infection and should not be used as the sole basis for treatment or other management decisions. The test is intended for professional and laboratory use.
Published September 12, 2012 · Recall initiated: March 9, 2012
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There have been reports of dual positive (Flu A + Flu B positive) results being encountered.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Princeton Biomeditech Corp
- Distributor
- Nationwide Distribution-including the states of NJ, NY, and PA.
- Lot
- 510 k K083746 Catalog Number 36022 Lot numbers 441H11 90 kits (22 tests per kit)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.